Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical hold
Biotech
Vyne prunes psoriasis trial, but keeps faith in BET inhibitor
Vyne has given up hope of resuming a psoriasis trial of its BET inhibitor under an FDA hold, but the biotech plans to persevere with the candidate.
James Waldron
Jul 2, 2025 10:33am
FDA slaps clinical hold on multiple Gilead HIV trials
Jun 10, 2025 10:48am
Rocket crashes as gene therapy patient dies, FDA imposes hold
May 27, 2025 9:49am
Atara lays off more staff despite FDA lifting clinical hold
May 13, 2025 10:07am
FDA lifts hold on Amgen's phase 1 obesity study
May 2, 2025 10:10am
Vyne’s psoriasis drug hit with FDA hold over testicular toxicity
Apr 25, 2025 9:25am
